Concepedia

Mary Jande

MJ

16

Publications

751

Citations

12

H-Index

1998

Active since

Affiliations

Karolinska Institutet(Current)

Catholic University of Health and Allied Sciences

Karolinska University Hospital

Muhimbili University of Health and Allied Sciences

University of Botswana

Mary Jande is an author at Karolinska Institutet specializing in medicine, public health, and pharmacotherapy.

Top concepts

Publications per year

1998–2017

16

Publications

16

4β-Hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians

Ulf Diczfalusy, Jun Miura, Hyung‐Keun Roh et al. · Pharmacogenetics and Genomics · 2008 · 145 citations

Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype*

Karin Herrlin, Amos Massele, Mary Jande et al. · Clinical Pharmacology & Therapeutics · 1998 · 94 citations

CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population

Rajaa A. Mirghani, Jane Sayi, Eleni Aklillu et al. · Pharmacogenetics and Genomics · 2006 · 86 citations

CYP3A5 Genotype has an Impact on the Metabolism of the HIV Protease Inhibitor Saquinavir

Filip Josephson, Annika Allqvist, Mohamed Janabi et al. · Clinical Pharmacology & Therapeutics · 2007 · 63 citations

Identification and phenotype characterization of two haplotypes causing different enzymatic capacity in fetal livers

Cristina Rodríguez‐Antona, Mary Jande, Anders Rane et al. · Clinical Pharmacology & Therapeutics · 2005 · 59 citations

Rows per page

1–5 of 16